Cargando…

Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI

OBJECTIVE: The prognostic value of the Liver Imaging Reporting and Data System (LI-RADS) 2018 in differentiating hepatocellular carcinoma (HCC) from other primary liver cancers (PLC) with cirrhosis is unclear. We aim to evaluate the value of LI-RADS 2018 with agent-enhanced MRI in the postoperative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yubo, Ni, Xiaoyan, Liu, Xinai, Yang, Chun, Wang, Yi, Lu, Xin, Zhou, Changwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010934/ https://www.ncbi.nlm.nih.gov/pubmed/36926054 http://dx.doi.org/10.2147/JHC.S394840

Ejemplares similares

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
por: Liu, Xinai, et al.
Publicado: (2022)

MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
por: Zhou, Changwu, et al.
Publicado: (2021)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
por: Fotouhi, Maryam, et al.
Publicado: (2023)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

CT/MRI LI-RADS v2017 – review of the guidelines
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC
por: Wen, Rong, et al.
Publicado: (2023)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
por: Moura Cunha, Guilherme, et al.
Publicado: (2021)

Standardizing liver imaging reporting and interpretation: LI-RADS and beyond
por: Rich, Nicole E., et al.
Publicado: (2023)

CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners
por: Patella, Francesca, et al.
Publicado: (2018)

Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?—a direct head-to-head meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

LI-RADS v2017 for liver nodules: how we read and report
por: Schima, Wolfgang, et al.
Publicado: (2018)

A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls
por: De Muzio, Federica, et al.
Publicado: (2022)

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI
por: Moon, Ji Yoon, et al.
Publicado: (2021)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

CEUS LI-RADS: a pictorial review
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2020)

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
por: Zhou, Yan, et al.
Publicado: (2022)

Diagnostic performance of ultrasonography-guided core-needle biopsy according to MRI LI-RADS diagnostic categories
por: Kim, Dong Wook, et al.
Publicado: (2021)

Usefulness of Arterial Subtraction in Applying Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Algorithm to Gadoxetic Acid-Enhanced MRI
por: Youn, Seo Yeon, et al.
Publicado: (2021)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
por: Wang, Ruizhi, et al.
Publicado: (2023)

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study
por: Ruan, Si-Min, et al.
Publicado: (2022)

Fully automating LI-RADS on MRI with deep learning-guided lesion segmentation, feature characterization, and score inference
por: Wang, Ke, et al.
Publicado: (2023)

Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
por: Wang, Peihua, et al.
Publicado: (2021)

Surgical Resection vs. Percutaneous Ablation for Single Hepatocellular Carcinoma: Exploring the Impact of Li-RADS Classification on Oncological Outcomes
por: Centonze, Leonardo, et al.
Publicado: (2021)

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
por: Kim, Tae Kyoung, et al.
Publicado: (2017)

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
por: An, Chansik, et al.
Publicado: (2016)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors
por: Wu, Yunan, et al.
Publicado: (2020)

Use of the LI-RADS classification in patients with cirrhosis due to infection with hepatitis B, C, or D, or infected with hepatitis B and D
por: Pereira, Rita de Cassia Ribeiro, et al.
Publicado: (2020)

Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification
por: Liu, Yongkai, et al.
Publicado: (2021)

The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System (LI-RADS) version 2018
por: Saleh, Gehad Ahmad, et al.
Publicado: (2022)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
por: Sheng, Ruofan, et al.
Publicado: (2021)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Cannella, Roberto, et al.
Publicado: (2021)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

CO-RADS: Coronavirus Classification Review
por: Penha, Diana, et al.
Publicado: (2021)

Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows
por: Granata, Vincenza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ii3p973ret6f48or7fqgiolu7s